Shankar Ramaswamy’s Kriya Therapeutics has acquired another gene therapy beginup for an undisclosed quantity.
Kriya has purchased Tramontane Therapeutics, a chronic liver disease gene therapy beginup out of Barcelona. Tramontane was spun out of the lab of one among Kriya’s scientific advertvisors, Fàtima Bosch, in 2021. Kriya has been working with Bosch since 2020, when it licensed a diabetes gene therapy professionalgram from Bosch’s lab.
Unlock this text immediately by turning into a free subscriber.
You’ll get entry to free articles every month, plus you may customise what newsletters get delivered to your inbox every week, together with breaking information.